News & Events
Events
BRCA Initiative Meeting
03 February 2026
09:00-12:00
The David and Janet Polak Visitors Center, Technion, Haifa
BRCA germline mutations are approximately ten times more prevalent in Israel compared to the general population. This increased prevalence provides a unique opportunity to study BRCA-associated cancers such as breast, ovarian, prostate, and pancreatic cancers.
About the initiative
BRCA-MAP is a pioneering research initiative committed to transforming the landscape of BRCA1/2-mutated cancers. By integrating cancer cell biology, multi-omics, basic sciences, AI-driven computational biology, predictive modeling, and advanced delivery platforms, we aim to harness patient-derived data to uncover novel biomarkers and therapeutic targets. Our goal is to revolutionize patient care—from early detection to breakthrough treatments for advanced-stage disease.
This initiative is for the researchers and clinicians affiliated with the Technion and the Broad Institute.
Event Agenda
09:00-09:25- Welcome and light breakfast.
09:30–10:30- Keynote talk by Prof. Carlos Caldas, a world-renowned clinician-scientist, recognized for transforming breast cancer research through functional genomics.
10:30–11:30- Brief 3-5-minute participants’ introductions.
11:30–12:00- Open discussion.
